[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20054674L - Benzotiazolderivatforbindelser, preperater og anvendelser - Google Patents

Benzotiazolderivatforbindelser, preperater og anvendelser

Info

Publication number
NO20054674L
NO20054674L NO20054674A NO20054674A NO20054674L NO 20054674 L NO20054674 L NO 20054674L NO 20054674 A NO20054674 A NO 20054674A NO 20054674 A NO20054674 A NO 20054674A NO 20054674 L NO20054674 L NO 20054674L
Authority
NO
Norway
Prior art keywords
preparations
applications
derivative compounds
benzothiazole derivative
benzothiazole
Prior art date
Application number
NO20054674A
Other languages
English (en)
Other versions
NO330861B1 (no
NO20054674D0 (no
Inventor
Jr Chester A Mathis
Yanming Wang
William E Klunk
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/388,173 external-priority patent/US7270800B2/en
Priority claimed from US10/645,847 external-priority patent/US20050043523A1/en
Priority claimed from PCT/US2004/007797 external-priority patent/WO2004083195A1/en
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Publication of NO20054674D0 publication Critical patent/NO20054674D0/no
Publication of NO20054674L publication Critical patent/NO20054674L/no
Publication of NO330861B1 publication Critical patent/NO330861B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20054674A 2003-03-14 2005-10-11 Benzotiazolavledede forbindelser, preparater og anvendelser NO330861B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/388,173 US7270800B2 (en) 2000-08-24 2003-03-14 Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US10/645,847 US20050043523A1 (en) 2003-08-22 2003-08-22 Benzothiazole derivative compounds, compositions and uses
PCT/US2004/007797 WO2004083195A1 (en) 2003-03-14 2004-03-15 Benzothiazole derivative compounds, compositions and uses

Publications (3)

Publication Number Publication Date
NO20054674D0 NO20054674D0 (no) 2005-10-11
NO20054674L true NO20054674L (no) 2005-12-13
NO330861B1 NO330861B1 (no) 2011-08-01

Family

ID=35057877

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20054674A NO330861B1 (no) 2003-03-14 2005-10-11 Benzotiazolavledede forbindelser, preparater og anvendelser
NO20110980A NO20110980L (no) 2003-03-14 2011-07-06 Benzotiazolavledede forbindelser, preparater og anvendelser
NO2015005C NO2015005I1 (no) 2003-03-14 2015-02-18 Flutemetamol (18F)

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20110980A NO20110980L (no) 2003-03-14 2011-07-06 Benzotiazolavledede forbindelser, preparater og anvendelser
NO2015005C NO2015005I1 (no) 2003-03-14 2015-02-18 Flutemetamol (18F)

Country Status (16)

Country Link
EP (1) EP1611115B1 (no)
JP (1) JP4875487B2 (no)
CN (2) CN102532055B (no)
AU (2) AU2004221897B2 (no)
BE (1) BE2015C005I2 (no)
BR (1) BRPI0408274B8 (no)
CY (2) CY1113334T1 (no)
DK (1) DK1611115T3 (no)
ES (1) ES2393921T3 (no)
HK (1) HK1086270A1 (no)
HU (1) HUS1500006I1 (no)
NO (3) NO330861B1 (no)
PL (1) PL1611115T3 (no)
PT (1) PT1611115E (no)
RU (1) RU2440995C2 (no)
SI (1) SI1611115T1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270800B2 (en) 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
BRPI0113470B8 (pt) 2000-08-24 2021-05-25 Univ Pittsburgh composto de ligação amilóide, composição farmacêutica e métodos de síntese de composto, de detecção in vivo de depósitos amilóides num indivíduo e em tecido humano ou animal, de quantificação de depósito amilóide em tecido de biópsia ou postmortem e de distinção de um cérebro de doença de alzheimer de um cérebro normal
EP1768968A1 (en) * 2004-05-20 2007-04-04 Foldrx Pharmaceuticals, Inc. 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process
US20100080432A1 (en) * 2007-01-30 2010-04-01 Johan Axel Lilja Tools for aiding in the diagnosis of neurodegenerative diseases
CN101293878B (zh) * 2007-04-25 2010-12-15 中国科学院上海应用物理研究所 苯并噻唑苯胺类化合物及其制备方法和应用
JP2011529086A (ja) * 2008-07-24 2011-12-01 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Ａｄ病変を同定するために有用な造影剤
US8895313B2 (en) * 2008-09-23 2014-11-25 Wista Laboratories Ltd. Ligands for aggregated tau molecules
MX2016003422A (es) 2013-09-26 2016-06-28 Hoffmann La Roche Imidazo[1,2-a]piridina-7-aminas como herramientas de imagen.
JP6260967B2 (ja) * 2013-11-06 2018-01-17 国立大学法人京都大学 放射性ヨウ素標識化合物、及び、これを含む放射性医薬
CN103613589B (zh) * 2013-11-29 2016-03-30 江苏华益科技有限公司 一种用于神经退行性疾病领域的新型pet显像剂前体及标准品的合成方法
MX2017002705A (es) * 2014-08-29 2017-12-20 Chdi Foundation Inc Sondas para la proyección de imagen de la proteína huntingtina.
CN109400615B (zh) * 2017-08-18 2021-07-16 上海交通大学医学院附属新华医院 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
GR1009516B (el) * 2018-03-22 2019-05-02 Εκεφε Δημοκριτος Τρικαρβονυλο-συμπλοκα μεταλλων μεταπτωσεως με βενζο-ετεροκυκλικο παραγωγο του κυκλοπενταδιενυλικου ανιοντος με υψηλη διαπερατοτητα του αιματοεγκεφαλικου φραγμου για εφαρμογες στη διαγνωση και θεραπεια νοσων του κνς

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9714358A (pt) * 1996-11-22 2000-03-21 Elan Pharm Inc Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
GB9919673D0 (en) * 1999-08-20 1999-10-20 Cancer Res Campaign Tech 2-Arlybenzazole compounds
BRPI0113470B8 (pt) * 2000-08-24 2021-05-25 Univ Pittsburgh composto de ligação amilóide, composição farmacêutica e métodos de síntese de composto, de detecção in vivo de depósitos amilóides num indivíduo e em tecido humano ou animal, de quantificação de depósito amilóide em tecido de biópsia ou postmortem e de distinção de um cérebro de doença de alzheimer de um cérebro normal
US7045539B2 (en) * 2000-12-22 2006-05-16 Astrazeneca Ab Therapeutic benzoxazole compounds
TWI245764B (en) * 2001-04-23 2005-12-21 Hank F Kung Amyloid plaque aggregation inhibitors and diagnostic imaging agents
GB0229686D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles

Also Published As

Publication number Publication date
BRPI0408274B8 (pt) 2021-05-25
AU2011200667A1 (en) 2011-03-10
EP1611115B1 (en) 2012-08-22
AU2011200667B2 (en) 2011-12-22
AU2004221897A9 (en) 2009-08-20
EP1611115A1 (en) 2006-01-04
JP2006522104A (ja) 2006-09-28
SI1611115T1 (sl) 2012-12-31
CN1784392A (zh) 2006-06-07
CY1113334T1 (el) 2015-12-09
PL1611115T3 (pl) 2013-01-31
AU2004221897A2 (en) 2004-09-30
JP4875487B2 (ja) 2012-02-15
RU2005131872A (ru) 2006-02-27
DK1611115T3 (da) 2012-11-26
BE2015C005I2 (no) 2023-03-07
NO330861B1 (no) 2011-08-01
HUS1500006I1 (hu) 2015-02-18
RU2440995C2 (ru) 2012-01-27
ES2393921T3 (es) 2013-01-02
BRPI0408274A (pt) 2006-03-21
CN102532055A (zh) 2012-07-04
NO2015005I2 (no) 2015-02-18
AU2004221897B2 (en) 2010-11-18
PT1611115E (pt) 2012-12-07
NO20054674D0 (no) 2005-10-11
HK1086270A1 (en) 2006-09-15
CN102532055B (zh) 2016-05-11
BRPI0408274B1 (pt) 2019-02-26
CY2015007I1 (el) 2015-12-09
NO20110980L (no) 2005-12-13
AU2004221897A1 (en) 2004-09-30
NO2015005I1 (no) 2015-03-02

Similar Documents

Publication Publication Date Title
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
ATE391505T1 (de) Benzothiazole derivative
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
DE60301683D1 (de) Leseverstärker
DK1654360T3 (da) Amplificering fremgangsmåde
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
ATE478870T1 (de) Spiroindolinpiperidinderivate
ATE460418T1 (de) Heterocyclocarboxamidderivate
ATE450506T1 (de) Indol-3-schwefelderivate
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
DK1682493T3 (da) Amidoacetonitrilderivater
IS7549A (is) Olíuleysanlegar efnablöndur
ATE352550T1 (de) Chinazolinderivate
DK1606277T3 (da) Imidazol-4-yl-ethynyl-pyridinderivater
IS8364A (is) N-þíasól-2-ýl-bensamíð afleiður
DE602004004230D1 (de) Klasse-D Verstärker
NO20054674L (no) Benzotiazolderivatforbindelser, preperater og anvendelser
DE502004002225D1 (de) Selbstemulgierende Zubereitungen
DE60307512D1 (de) 3h-chinazoline -4-on derivaten
NO20054135D0 (no) Kipolinon/benzoksazin derivater og anvendelser derav
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
ATE423771T1 (de) Tetrahydrochinolinderivate

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822

Spc suppl protection certif: 2015005

Filing date: 20150218

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822; FIRST REG. NO/DATE: EU/1/14/941 20140822;

Spc suppl protection certif: 2015005

Filing date: 20150218

Extension date: 20290315